James C. Czirr
2014
In 2014, James C. Czirr earned a total compensation of $1.1M as Executive Chairman and Director at Galectin Therapeutics, a 149% increase compared to previous year.
Compensation breakdown
| Bonus | $84,000 |
|---|---|
| Option Awards | $688,367 |
| Salary | $240,000 |
| Other | $75,882 |
| Total | $1,088,249 |
Czirr received $688.4K in option awards, accounting for 63% of the total pay in 2014.
Czirr also received $84K in bonus, $240K in salary and $75.9K in other compensation.
Rankings
In 2014, James C. Czirr's compensation ranked 7,223rd out of 13,032 executives tracked by ExecPay. In other words, Czirr earned more than 44.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,223 out of 13,032 | 45th |
Division Manufacturing | 2,661 out of 4,966 | 46th |
Major group Chemicals And Allied Products | 902 out of 1,686 | 47th |
Industry group Drugs | 709 out of 1,365 | 48th |
Industry Pharmaceutical Preparations | 545 out of 1,043 | 48th |
Source: SEC filing on November 10, 2016.
Czirr's colleagues
We found three more compensation records of executives who worked with James C. Czirr at Galectin Therapeutics in 2014.